International Patent: METHODS AND SYSTEMS FOR PREDICTING RESPONSE, MONITORING, AND OPTIMIZING CDK4/6 INHIBITOR THERAPY USING EPIGENETIC METHYLATION BIOMARKERS

GENEVA, Oct. 30 -- GUARDANT HEALTH, INC. filed a patent application (US2026/025431) for “METHODS AND SYSTEMS FOR PREDICTING RESPONSE, MONITORING, AND OPTIMIZING CDK4/6 INHIBITOR THERAPY USING EPIGENETIC METHYLATION BIOMARKERS”. With publication no. WO/2026/227069, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/6886

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....